A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma.
about
Cabozantinib in the treatment of hepatocellular carcinoma.Role of miR-128 in hypertension-induced myocardial injury.Cholangiocarcinoma - evolving concepts and therapeutic strategies.Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatment.Cabozantinib in Patients with Advanced Merkel Cell Carcinoma.Targeting MET in cancer therapy.Emerging role of precision medicine in biliary tract cancers
P2860
Q38658285-A07B22CF-9A02-4141-B80A-A1EB7CB440BAQ41530165-036C3D08-A66B-49B8-85FA-0F388581D0A2Q46087686-4B62F2E2-27ED-43AA-9288-6D61AFC9760FQ50575839-35825B14-4563-4D20-9D0C-BE9262356B21Q51751201-D19DBD75-39D5-45A6-9377-4CB37ECFF9CEQ54987450-D9D5FBC1-A0DD-4D46-A2EC-F2EFE9E9A630Q57298169-BF77E651-A20B-49BB-9038-2A3207633C51
P2860
A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A phase 2 and biomarker study ...... h advanced cholangiocarcinoma.
@en
A phase 2 and biomarker study ...... h advanced cholangiocarcinoma.
@nl
type
label
A phase 2 and biomarker study ...... h advanced cholangiocarcinoma.
@en
A phase 2 and biomarker study ...... h advanced cholangiocarcinoma.
@nl
prefLabel
A phase 2 and biomarker study ...... h advanced cholangiocarcinoma.
@en
A phase 2 and biomarker study ...... h advanced cholangiocarcinoma.
@nl
P2093
P2860
P356
P1433
P1476
A phase 2 and biomarker study ...... h advanced cholangiocarcinoma.
@en
P2093
Amanda Reardon
Andrew X Zhu
Anna Khachatryan
Dan G Duda
Darrell R Borger
Eileen Regan
James M Cleary
Jill N Allen
Lipika Goyal
P2860
P304
P356
10.1002/CNCR.30571
P407
P577
2017-02-13T00:00:00Z